Acute coronary syndromes: The unfulfilled promise of erythropoietin in patients with MI

Nature Reviews Cardiology

Volumn 8, Issue 8, 2011, Pages 425-426

  Van Der Meer, Peter ^a   Van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ACUTE HEART INFARCTION; ANEMIA; ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; COMORBIDITY; ENDOTHELIUM CELL; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION TIME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HUMAN; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE DRUG DOSE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; TREATMENT OUTCOME;

ANIMALS; CARDIOVASCULAR AGENTS; ERYTHROPOIETIN; EVIDENCE-BASED MEDICINE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 79960967708     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2011.102     Document Type: Article

References (10)

1. Najjar, S. S. et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA 305, 1863-1872 (2011).
2. van Veldhuisen, D. J., Anker, S. D., Ponikowski, P. & Macdougall, I. C. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat. Rev. Cardiol. doi:101038/nrcardio.201177
3. Lipsic, E. et al. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J. Am. Coll. Cardiol. 48, 2161-2167 (2006). (Pubitemid 44855436)
4. Lipsic, E. et al. A single bolus of a long-acting erythropoietin analog darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study. Cardiovasc. Drugs Ther. 20, 135-141 (2006). (Pubitemid 43876097)
5. Voors, A. A. et al. A single dose of erythropoietin in ST-elevation myocardial infarction. Eur. Heart J. 31, 2593-2600 (2010).
6. Ott, I. et al. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial. Circ. Cardiovasc. Interv. 3, 408-413 (2010).
7. Suh, J. W. et al. The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention. Int. J. Cardiol. 149, 216-220 (2011).
8. Binbrek, A. S., Rao, N. S., Al, K. N., Assaqqaf, J. & Sobel, B. E. Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction. Am. J. Cardiol. 104, 1035-1040 (2009).
9. Liem, A. et al. Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study. Int. J. Cardiol. 131, 285-287 (2009).
10. Lipsic, E. et al. Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing hematocrit. Eur. J. Heart Fail. 10, 22-29 (2008).